Crossmark

Optimization of dosing regimens for the long-acting growth hormone pegpesen: A population PK/PD modeling approach

Published Online: 2025-11-05

Authors

Zhao, Youni

Zou, Fenfang

Gu, Jianbo

He, Ruoyi

Yin, Yalin https://orcid.org/0000-0002-7919-9571
Funding

Funding for this research was provided by:

Xiamen Amoytop Biotech Co., Ltd. (Xiamen Amoytop Biotech Co., Ltd.)
License Information

Text and Data Mining valid from 2025-11-05

Version of Record valid from 2025-11-05
More Information

Article History

Received: 13 August 2025

Accepted: 29 October 2025

First Online: 5 November 2025

Declarations

:

: All the authors are employees of Xiamen Amoytop Biotech Co., Ltd.

Document is current